









Markets
/
Stocks
/
nasdaq-tdacu
/

Translational Development Acquisition Corp

TDACU

11.000USD

0.000

Close 12/31, 16:00（ET）Quotes delayed by 15 min

0.00Market Cap

--P/E TTM



Translational Development Acquisition Corp

11.000

0.000

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can find the annual or quarterly income statement of Translational Development Acquisition Corp here for insights into the performance and operational efficiency of Translational Development Acquisition Corp.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024Q3

FY2023Q4

FY2023Q3

Operating expenses

12156.60%61.28K

--483.85K

--500.00

Operating profit

-12156.60%-61.28K

---483.85K

---500.00

Net non-operating interest income (expenses)

Income before tax

-12156.60%-61.28K

---483.85K

---500.00

Income after tax

-12156.60%-61.28K

---483.85K

---500.00

Net income from continuous operations

-12156.60%-61.28K

---483.85K

---500.00

Net income attributable to controlling interests

-12156.60%-61.28K

---483.85K

---500.00

Net income attributable to common shareholders

-12156.60%-61.28K

---483.85K

---500.00

Basic earnings per share

-10633.33%0.00

---0.03

--0.00

Diluted earnings per share

-10633.33%0.00

---0.03

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

